Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages
Aspirin Versus Clopidogrel Effect on Uterine Perfusion in Women With Unexplained Recurrent Pregnancy Loss With Decreased Uterine Artery Pulsatility Index: A Randomized Controlled Trial
Sponsor: Ain Shams University
This PHASE2/PHASE3 trial investigates Recurrent Pregnancy Loss and is currently ongoing. Ain Shams University leads this study, which shows 8 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE2/PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2/PHASE3
Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2_PHASE3
-
Apr 2019 — Jan 2021 [monthly]
Unknown Status PHASE2_PHASE3
Status: Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Apr 2017 — Jun 2018 [monthly]
Recruiting PHASE2_PHASE3
Status: Unknown Status → Recruiting
-
Jan 2017 — Apr 2017 [monthly]
Unknown Status PHASE2_PHASE3
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ain Shams University
For direct contact, visit the study record on ClinicalTrials.gov .